University at Buffalo (UB)
Our department achieves high standards of education, research and patient care, all with the goal of bringing nuclear medicine to a new level.
Welcome to the Department of Nuclear Medicine. Founded in 1972, the objectives of the Department are to support all aspects of Nuclear Medicine including Education, Research, and Clinical Service.
The UB Department of Nuclear Medicine has long been committed to providing the best in Nuclear Medicine Services to the community while maintaining high-quality training programs and providing educational, research and practice opportunities to physicians, pharmacists, physicists, medical students, residents, fellows, and technologists interested in the Nuclear Medicine Sciences.
Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and determine the severity of or treat a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body. Because nuclear medicine procedures are able to pinpoint molecular activity within the body, they offer the potential to identify disease in its earliest stages as well as a patient’s immediate response to therapeutic interventions.
Unlike conventional imaging studies that produce primarily structural pictures, nuclear medicine and molecular imaging visualize how the body is functioning and what’s happening at the cellular and molecular level. The evolution in diagnostic imaging—from producing anatomical pictures to imaging and measuring the body’s physiological processes—is critically important to all facets of medicine today, from diagnosing disease at its earliest stage and developing more effective therapies, to personalizing medical treatment.
With the help of nuclear medicine and molecular imaging, scientists and healthcare providers are:
Department of Nuclear Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, is a diverse group of faculty and staff engaged in three distinct, but overlapping activities of clinical service, education and research in the diagnostic and therapeutic use of radiopharmaceuticals and related instrumentation, with a predominant emphasis on molecular imaging.
Clinical service excellence will be shown by our regional market share and extra-regional referral patterns. Education excellence will be reflected in an American Board of Nuclear Medicine pass rate approaching 100%, continued graduation of high-caliber Nuclear Medicine Technologists and by an array of post-graduate fellowships including Neuromolecular Imaging, PET/CT and Physics. Research excellence will be demonstrated by profuse publications, presentations at prestigious national and international meetings and substantive, continuous external funding.
Although our capabilities range across the breadth of Nuclear Medicine and Molecular Imaging activities, we are distinguished from others in clinical service by our endocrine imaging, imaging of the central nervous system and PET/CT of oncology. In education we are distinguished by the breadth of our Nuclear Medicine Residency program, our Nuclear Medicine Technology program and our continuing education program. In research we excel in neuroscience, development of new PET radiopharmaceuticals, cyclotron instrumentation and targetry and development of new hybrid imaging devices.
The Department of Nuclear Medicine is firmly dedicated to developing and sustaining a nurturing, inclusive and welcoming environment for all. We believe that diversity in our faculty, students and staff is essential to the success of our education, research and service missions. We respect and support human diversity in all its aspects – including gender, race, ethnicity, age, religion, language, ability, sexual orientation, veteran status and socio-economic status.